Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Rachel Roberts-Thomson
Optimizing Combination Dabrafenib and Trametinib Therapy in BRAF Mutation-Positive Advanced Melanoma Patients: Guidelines From Australian Melanoma Medical Oncologists
Asia-Pacific Journal of Clinical Oncology
Medicine
Oncology
Related publications
Dabrafenib and Trametinib in BRAF Mutant Metastatic Conjunctival Melanoma
Frontiers in Oncology
Cancer Research
Oncology
Ipilimumab, Vemurafenib, Dabrafenib, and Trametinib: Synergistic Competitors in the Clinical Management of BRAF Mutant Malignant Melanoma
Oncologist
Cancer Research
Medicine
Oncology
Improved Overall Survival in Melanoma With Combined Dabrafenib and Trametinib
New England Journal of Medicine
Medicine
Cost-Utility Analysis of Dabrafenib/Trametinib Combination (D+t) for Brafv600 Mutation-Positive Metastatic Melanoma (Mm) From the United Kingdom (Uk) National Health Service (Nhs) Perspective
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Combination Therapy With BRAF and MEK Inhibitors for Melanoma: Latest Evidence and Place in Therapy
Therapeutic Advances in Medical Oncology
Oncology
BRAF G596R Mutation in a Slow-Progressing Melanoma
Pathology and Laboratory Medicine International
Ineffective Anti PD-1 Therapy After BRAF Inhibitor Failure in Advanced Melanoma
BMC Cancer
Cancer Research
Oncology
Genetics
Survival Outcomes in Patients With Previously Untreated BRAF Wild-Type Advanced Melanoma Treated With Nivolumab Therapy
JAMA Oncology
Cancer Research
Oncology
Granulomatosis With Polyangiitis in a Patient Treated With Dabrafenib and Trametinib for BRAF V600E Positive Lung Adenocarcinoma
BMC Cancer
Cancer Research
Oncology
Genetics
